Kevin S. Orwig

Array ( [id] => 19430989 [patent_doc_number] => 20240299487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => ANTIVIRAL COMPOSITION COMPRISING A NUCLEOLIN-BINDING PEPTIDE [patent_app_type] => utility [patent_app_number] => 18/549549 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20262209 [patent_doc_number] => RE050621 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-07 [patent_title] => Detecting breast cancer [patent_app_type] => reissue [patent_app_number] => 17/735477 [patent_app_country] => US [patent_app_date] => 2022-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42095 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18869883 [patent_doc_number] => 11857663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Stable silk protein fragment compositions [patent_app_type] => utility [patent_app_number] => 17/716730 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 248 [patent_no_of_words] => 38010 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17748020 [patent_doc_number] => 20220226223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => Stable Silk Protein Fragment Compositions [patent_app_type] => utility [patent_app_number] => 17/716743 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19417382 [patent_doc_number] => 20240293505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V [patent_app_type] => utility [patent_app_number] => 18/282152 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18700089 [patent_doc_number] => 11786575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Endoparasitic depsipeptides [patent_app_type] => utility [patent_app_number] => 17/696955 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53027 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18140799 [patent_doc_number] => 20230014640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME [patent_app_type] => utility [patent_app_number] => 17/684742 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18817484 [patent_doc_number] => 20230391824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => RATIONALE, DESIGN, SYNTHESIS AND VALIDATION OF A SMALL MOLECULE ANTICANCER AGENT [patent_app_type] => utility [patent_app_number] => 18/275678 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17748106 [patent_doc_number] => 20220226309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/666304 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19975284 [patent_doc_number] => RE050474 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-07-01 [patent_title] => Antiviral agents [patent_app_type] => reissue [patent_app_number] => 17/569453 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 34 [patent_no_of_words] => 10364 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18732561 [patent_doc_number] => 11801281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Tissue occluding agent comprising an ieikieikieiki peptide [patent_app_type] => utility [patent_app_number] => 17/568026 [patent_app_country] => US [patent_app_date] => 2022-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9115 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17568026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17655544 [patent_doc_number] => 20220176009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHOD FOR PREPARING ABSORBABLE HAEMOSTATIC COMPOSITION FOR BODY AND HAEMOSTATIC COMPOSITION PREPARED THEREBY [patent_app_type] => utility [patent_app_number] => 17/542946 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18886457 [patent_doc_number] => 11865213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Semaglutide depot systems and use thereof [patent_app_type] => utility [patent_app_number] => 17/534533 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 29 [patent_no_of_words] => 15595 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17458782 [patent_doc_number] => 20220072086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME [patent_app_type] => utility [patent_app_number] => 17/529861 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19603 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17609658 [patent_doc_number] => 20220151937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => COMPOSITION FOR NAP PROMOTION [patent_app_type] => utility [patent_app_number] => 17/529160 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4934 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18860043 [patent_doc_number] => 20230414477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES [patent_app_type] => utility [patent_app_number] => 18/037480 [patent_app_country] => US [patent_app_date] => 2021-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17734695 [patent_doc_number] => 20220220154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/506523 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506523 [rel_patent_id] =>[rel_patent_doc_number] =>)